The Non-Destructive Biomedical and Pharmaceutical Research Centre is a fruit of collaboration with the Faculty of Electrical Engineering, Universiti Teknologi MARA (UiTM). It is set up in the year of 2006 following the approval of Ministry of Higher Education, Malaysia as well as Lembaga Pengarah Universiti and Senate. It is located in the campus of UiTM at Puncak Alam, Selangor.
The research centre conducts postgraduate study, both at the MSc and Ph.D levels. Intra- and inter-universities, as well as, industry-university research collaborations are initiated, both locally and internationally, by the research centre.
The research direction of the centre mainly focuses on
The Non-Destructive Biomedical and Pharmaceutical Research Centre is supported by the Particle Design Research Group, UiTM which was set up in the year of 2004. The group mainly focuses on design of particulate drug delivery systems and molecular pharmaceutics in which the molecular details of pharmaceutical materials are elucidated and defined in relation to the need to predict their biological as well as physicochemical properties essential in design of drug delivery systems.
Research study directs at innovative design of multi-particulate drug delivery systems such as nanoparticles, microparticles and agglomerates for treatment of diabetes, melanoma, tuberculosis and colon cancer, via the invention and application of breakthrough pharmaceutical technology. In addition, films for the application in transdermal and topical drug delivery are invented.
Research study directs at elucidation and analysis of structure-property relationships of pharmaceutical polymers and drugs
Research study directs at invention of novel pharmaceutical technology in relation to the need of drug targeting for treatment of medical illnesses such as diabetes and colon cancer.
Research study directs at animal study in examination of the functional properties of drug delivery systems, biological effects of polymers and drugs, as well as, drug targeting property of the intended dosage form.